ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2557

Tumor Necrosis Factor (TNF) Sensitizes Rheumatoid Synovial Fibroblasts to TRPA1-Mediated Calcium Flux, Anti-Proliferation and Cell Death

Torsten Lowin1, Rainer Straub2 and Georg Pongratz3, 1Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany, 2Laboratory of Experimental Rheumatology and Neuroendocrine Immunology, Department of Internal Medicine, University Hospital Regensburg, Regensburg, Germany, 3Rheumatology - Hiller Research Center Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Apoptosis, Calcium, synovial cells, synovial fluid and tumor necrosis factor (TNF)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  In rheumatoid arthritis (RA), synovial fibroblasts (SF) are one main contributor of joint destruction since they resist apoptosis and secrete pro-inflammatory cytokines and matrix degrading enzymes. Previous studies already demonstrated the functional expression of several transient receptor potential channels (TRP) such as TRPV1, TRPV2, TRPV4, TRPA1 and TRPM8 in SF. Upon ligation, these receptors increase intracellular calcium but they have also been linked to modulation of inflammation in several cell types. TNF was shown to increase the expression of TRPA1, the receptor for mustard oil (allylisothiocyanate, AITC) and environmental poisons in synovial fibroblasts, but the functional consequences have not been investigated yet.

Methods:  TRPA1 was detected by immunocytochemistry and western blot. Calcium signals were determined fluorometrically (Fura-AM red). Cell viability was assessed by quantification of lactate dehydrogenase (LDH) in culture supernatants. IL-6, IL-8 and MMP-3 were determined by ELISA. Proliferation was determined by cell titer blue incorporation.

Results:  After 72h, TNF up-regulated TRPA1 protein levels in RASF which was accompanied by increased sensitivity to TRPA1 agonists AITC and polygodial. Under unstimulated conditions, polygodial but not AITC elicited modest calcium flux only in the highest concentrations used (50µM and 25µM). TNF pre-incubation substantially lowered the activation threshold for polygodial (from 25µM to1µM) and enabled AITC-mediated calcium flux, which was inhibited by TRPA1 antagonists A967079 (25µM) and HC030031 (50µM). In addition, TNF stimulation strongly enhanced TRPA1 mediated LDH release by AITC and polygodial, a marker for cell death. TNF not only reduced the threshold of AITC and polygodial but also led to a faster onset of LDH release. Furthermore, TRPA1 activation was associated with decreased proliferation of RASFs with TNF pre-incubation enhancing the anti-proliferative effect of AITC and polygodial. Secretion of IL-6, IL-8 and MMP-3 was attenuated by the TRPA1 antagonist A967079 but also polygodial, although the latter mediated this effect by reducing cell viability.

Conclusion:  TNF up-regulates and sensitizes TRPA1 in RASF. Subsequent activation of TRPA1 increased calcium flux and reduced cell viability. Since TRPA1 agonists only showed effects in TNF stimulated RASF, this cation channel might an attractive therapeutic target in chronic inflammation to reduce the activity of pro-inflammatory SF in the joint.


Disclosure: T. Lowin, None; R. Straub, None; G. Pongratz, None.

To cite this abstract in AMA style:

Lowin T, Straub R, Pongratz G. Tumor Necrosis Factor (TNF) Sensitizes Rheumatoid Synovial Fibroblasts to TRPA1-Mediated Calcium Flux, Anti-Proliferation and Cell Death [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/tumor-necrosis-factor-tnf-sensitizes-rheumatoid-synovial-fibroblasts-to-trpa1-mediated-calcium-flux-anti-proliferation-and-cell-death/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tumor-necrosis-factor-tnf-sensitizes-rheumatoid-synovial-fibroblasts-to-trpa1-mediated-calcium-flux-anti-proliferation-and-cell-death/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology